Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma.
Jufriady IsmyDessy R EmrilSaid Alfin KhalilullahMuhammad Puteh MaunyPublished in: Journal of pain research (2023)
The conclusion of this research is that gabapentin is effective in the treatment of BTcP caused by metastatic prostate adenocarcinoma.